atovaquone
(Atovaquone)Avion Pharmaceuticals, LLC
Usage: Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents (age 13 and older) who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Its use is limited to cases categorized as mild-to-moderate PCP.